EUVIMEDEUVIMED entdecken
Crossref

Successful implantation of an active transcutaneous bone conduction implant system in 3-year-old children

Kerstin Willenborg, Susan Busch, Thomas Lenarz

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S247

DOI: 10.1055/s-0044-1784813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Kerstin Willenborg und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The MedEl Bonebridge system is an active transcutaneous bone conduction implant system for patients with conductive and mixed hearing loss but can also be used in cases of single-sided deafness. Children above three years of age with a lesser bone thickness were previously mainly treated with a percutaneous osseointegrated bone-anchored hearing aid (BAHA) due to its low depth of insertion into the bone or an active middle-ear implant which does not require anchoring in bone but both of these interventions have limitations and risks of complications like dislocation and infection potentially leading to revision surgery. These complications can be omitted with active transcutaneous bone conduction implant systems. The second generation of the Bonebridge (BCI 602) features a decreased thickness of the implant with reduced drilling depth and can thus be implanted in younger children. Methodology 3-year-old children with aural atresia were implanted with the second generation of the Bonebridge. Preoperative Workup comprised a CT scan, a MRI scan, and an ABR (bone and air conduction). The computed tomography was performed to measure bone thickness and to determine the consistency of the temporal bone using the Otoplan software in order to find the optimal position for the implant.

Results

All patients were successfully implanted. No severe adverse effects were observed. All showed a good postoperative hearing performance.

Discussion

With adequate preoperative workup and planning, this device can be safely implanted in 3-year-old children with a beneficial postoperative audiological outcome and without adverse effects. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Willenborg, K., Busch, S., & Lenarz, T. (2024). Successful implantation of an active transcutaneous bone conduction implant system in 3-year-old children. Laryngo-Rhino-Otologie, 103(S 02 S 02), S247. https://doi.org/10.1055/s-0044-1784813

Vancouver

Willenborg K, Busch S, Lenarz T. Successful implantation of an active transcutaneous bone conduction implant system in 3-year-old children. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S247. doi:10.1055/s-0044-1784813

BibTeX
@article{Willenborg2024,
  author = {Willenborg, Kerstin and Busch, Susan and Lenarz, Thomas},
  title = {Successful implantation of an active transcutaneous bone conduction implant system in 3-year-old children},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S247},
  doi = {10.1055/s-0044-1784813}
}
Kostenlos starten →